Continuing Medical Education (CME)

Online Courses

Title:	Taking Charge : New Science for Continuous Oral Contraceptive Use
Program Developers:	*Prepared By:* Timothy Rowe , MB, FRCSC Associate Professor, Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver B.C. Robert L. Reid , MD, Professor, Queen’s University, Kingston Ontario. *Reviewed By:* Owen Peter Hughes, MD, FCFP, CCFP Assistant Professor- Faculty of Medicine University of Ottawa Head- Division of Maternal and Newborn Care The Ottawa Hospital Ottawa, Ontario
Course Dates:	Beginning March 15th, 2007 and ending March 15th , 2007.
Learning Objectives:	Following this module, participants will be able: Understand the normal menstrual cycle and how oral contraceptives act on the menstrual cycle Discuss the history of hormonal oral contraception Be familiar with the risks and benefits of continuous OC and cyclic OC use Understand the different psychosocial attitudes of individuals when presented with choices regarding continuous and cycle OC use.
Description:	Many women have concerns regarding menstrual suppression that are not related to the safety of the product. These concerns include the symptoms associated with the one week withdrawal of the contraceptive to allow normal menstrual bleeding and psychosocial attitudes regarding the menstrual period. Roughly 75% to 85% of menstruating women report some degree of premenstrual or menstrual symptoms. Many women experience significant levels of headache, fatigue, nausea, acne, breast tenderness, bloating, weight gain, tension or anxiety, depression, and mood swings. About one third of women experience symptoms severe enough to interfere with daily activities. Menstrual disorders affect nearly 2.5 million US women aged 18 to 50 years and most seek medical assistance at least once per year. Almost one third of these women report spending an average of 10 days in bed each year because of the symptoms.
Accreditation:	This program meets the accreditation criteria of The College of Family Physicians of Canada and has been accredited for up to 1.0 MAINPRO-M1 credit.This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.
Cost:	This case study is free to all physicians.
Supported by:	Unrestricted educational grant received from Wyeth Pharmaceuticals.
Presented by:	AdvancingIn
Specialty:	Community Medicine, Family Medicine, Obstetrics, Gynecology

Last Updated March 27, 2007